Our
Technologies

External and implantable neuromodulation platforms built to deliver ARC Therapy™

All ONWARD^® Medical therapies are investigational and not available for commercial use.

Our Mission

Driven to restore
Movement
Function
Independence
in people with spinal cord injury

Discover Our Therapy

ARC Therapy is targeted stimulation of the spinal cord designed to restore upper and lower limb movement and other functions, such as blood pressure regulation, after SCI.

Our external ARC^EX® System is built to non-invasively deliver ARC^EX Therapy, and our implantable ARC^IM® and ARC^BCI™ Systems are built to minimally invasively deliver ARC^IM Therapy.

These benefits have been observed in published pre-clinical and human feasibility studies.

Clinical results may vary.
Investigational and not available for commercial use.

Watch how it works

ARC Therapy is targeted stimulation of the spinal cord designed to restore upper and lower limb movement and other functions, such as blood pressure regulation, after SCI.

Our external ARC^EX® System is built to non-invasively deliver ARC^EX Therapy, and our implantable ARC^IM® and ARC^BCI™ Systems are built to minimally invasively deliver ARC^IM Therapy.

These benefits have been observed in published pre-clinical and human feasibility studies.

Clinical results may vary.
Investigational and not available for commercial use.
Watch how it works

External Platform

Investigational, spinal cord stimulation platform to non-invasively deliver targeted ARC^EX Therapy to the spinal cord.

The US FDA granted the ARC^EX platform Breakthrough Device Designations for improvement of upper and lower limb function, bladder control, regulation of blood pressure, and alleviation of spasticity in people with spinal cord injury.

Learn more

Investigational, spinal cord stimulation platform to non-invasively deliver targeted ARC^EX Therapy to the spinal cord.

The US FDA granted the ARC^EX platform Breakthrough Device Designations for improvement of upper and lower limb function, bladder control, regulation of blood pressure, and alleviation of spasticity in people with spinal cord injury.
Learn more

Implantable Platform

Investigational, neurostimulation platform to minimally invasively deliver targeted ARC^IM Therapy to the spinal cord.

The US FDA awarded the ARC^IM platform Breakthrough Device Designations for restoration of leg motor function, blood pressure regulation, trunk stabilization, bladder control, and alleviation of spasticity in people with spinal cord injury.

Learn more

Investigational, neurostimulation platform to minimally invasively deliver targeted ARC^IM Therapy to the spinal cord.

The US FDA awarded the ARC^IM platform Breakthrough Device Designations for restoration of leg motor function, blood pressure regulation, trunk stabilization, bladder control, and alleviation of spasticity in people with spinal cord injury.
Learn more

Implantable Platform

Investigational system that pairs ARC^IM Therapy with a brain-computer interface (BCI) to restore thought-driven movement of the upper and lower limbs.

In partnership with EPFL and CEA-Clinatec, in 2021 we successfully implanted an investigational BCI in a human to augment our ARC^IM Therapy with thought-driven movement of the legs after paralysis. The approach was published in Nature in May 2023.

With a European Innovation Council grant to study restoration of thought-driven arm and hand movement after SCI, an additional human was implanted with ARC^IM Therapy + BCI in 2023. Three more people are scheduled to participate in the study in 2024.

Learn more

Investigational system that pairs ARC^IM Therapy with a brain-computer interface (BCI) to restore thought-driven movement of the upper and lower limbs.

In partnership with EPFL and CEA-Clinatec, in 2021 we successfully implanted an investigational BCI in a human to augment our ARC^IM Therapy with thought-driven movement of the legs after paralysis. The approach was published in Nature in May 2023.

With a European Innovation Council grant to study restoration of thought-driven arm and hand movement after SCI, an additional human was implanted with ARC^IM Therapy + BCI in 2023. Three more people are scheduled to participate in the study in 2024.
Learn more

Read Our Publications

Learn more

Contact Us

Please fill out the form
if you would like to contact
us or receive updates

Complete form

All ONWARD^® Medical devices and therapies referenced here, including but not limited to ARC^IM®, ARC^EX®, ARC^BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

Our
Technologies

External and implantable neuromodulation platforms built to deliver ARC Therapy™

Meet David Mzee and learn about his journey

Our Mission

Driven to restore
Movement
Function
Independence
in people with spinal cord injury

Discover Our Therapy

Discover Our Therapy

External Platform

External Platform

Investigational, spinal cord stimulation platform to non-invasively deliver targeted ARC^EX Therapy to the spinal cord.

Investigational, spinal cord stimulation platform to non-invasively deliver targeted ARC^EX Therapy to the spinal cord.

Implantable Platform

Implantable Platform

Investigational, neurostimulation platform to minimally invasively deliver targeted ARC^IM Therapy to the spinal cord.

Investigational, neurostimulation platform to minimally invasively deliver targeted ARC^IM Therapy to the spinal cord.

Implantable Platform

Implantable Platform

Investigational system that pairs ARC^IM Therapy with a brain-computer interface (BCI) to restore thought-driven movement of the upper and lower limbs.

Investigational system that pairs ARC^IM Therapy with a brain-computer interface (BCI) to restore thought-driven movement of the upper and lower limbs.

Read Our Publications

Non-invasive spinal cord electrical stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial

Nature Medicine

A spinal cord neuroprosthesis for locomotor deficits due to Parkinson’s disease

Nature Medicine

Walking naturally after spinal cord injury using a brain–spine interface

Nature

The neurons that restore walking after paralysis

Nature

Contact Us

Please fill out the form
if you would like to contact
us or receive updates

All ONWARD^® Medical devices and therapies referenced here, including but not limited to ARC^IM®, ARC^EX®, ARC^BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

Our Technologies

External and implantable neuromodulation platforms built to deliver ARC Therapy™

Meet David Mzee and learn about his journey

Our Mission

Driven to restore Movement Function Independence in people with spinal cord injury

Discover Our Therapy

Discover Our Therapy

External Platform

External Platform

Investigational, spinal cord stimulation platform to non-invasively deliver targeted ARCEX Therapy to the spinal cord.

Investigational, spinal cord stimulation platform to non-invasively deliver targeted ARCEX Therapy to the spinal cord.

Implantable Platform

Implantable Platform

Investigational, neurostimulation platform to minimally invasively deliver targeted ARCIM Therapy to the spinal cord.

Investigational, neurostimulation platform to minimally invasively deliver targeted ARCIM Therapy to the spinal cord.

Implantable Platform

Implantable Platform

Investigational system that pairs ARCIM Therapy with a brain-computer interface (BCI) to restore thought-driven movement of the upper and lower limbs.

Investigational system that pairs ARCIM Therapy with a brain-computer interface (BCI) to restore thought-driven movement of the upper and lower limbs.

Read Our Publications

Non-invasive spinal cord electrical stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial

Nature Medicine

A spinal cord neuroprosthesis for locomotor deficits due to Parkinson’s disease

Nature Medicine

Walking naturally after spinal cord injury using a brain–spine interface

Nature

The neurons that restore walking after paralysis

Nature

Contact Us

Please fill out the form if you would like to contact us or receive updates

All ONWARD® Medical devices and therapies referenced here, including but not limited to ARCIM®, ARCEX®, ARCBCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

Our
Technologies

Driven to restore
Movement
Function
Independence
in people with spinal cord injury

Investigational, spinal cord stimulation platform to non-invasively deliver targeted ARC^EX Therapy to the spinal cord.

Investigational, spinal cord stimulation platform to non-invasively deliver targeted ARC^EX Therapy to the spinal cord.

Investigational, neurostimulation platform to minimally invasively deliver targeted ARC^IM Therapy to the spinal cord.

Investigational, neurostimulation platform to minimally invasively deliver targeted ARC^IM Therapy to the spinal cord.

Investigational system that pairs ARC^IM Therapy with a brain-computer interface (BCI) to restore thought-driven movement of the upper and lower limbs.

Investigational system that pairs ARC^IM Therapy with a brain-computer interface (BCI) to restore thought-driven movement of the upper and lower limbs.

Please fill out the form
if you would like to contact
us or receive updates

All ONWARD^® Medical devices and therapies referenced here, including but not limited to ARC^IM®, ARC^EX®, ARC^BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.